Literature DB >> 24135155

25-Hydroxyvitamin D and cognitive performance in mid-life.

Jane Maddock1, Marie-Claude Geoffroy1, Chris Power1, Elina Hyppönen1.   

Abstract

Hypovitaminosis D has been linked with poor cognitive function, particularly in older adults, but studies lack a lifespan approach; hence, the effects of reverse causality remain unknown. In the present study, we aimed to assess the relationship between 25-hydroxyvitamin D (25(OH)D) concentrations and subsequent cognitive performance in mid-adulthood and the influence of earlier life factors, including childhood cognitive ability, on this association. Information for the present study was obtained from the members of the 1958 British birth cohort (n 6496). Serum 25(OH)D concentration, indicating vitamin D status, was measured at age 45 years. Verbal memory (immediate and delayed word recall), verbal fluency (animal naming) and speed of processing were tested at age 50 years. Information on childhood cognitive ability, educational attainment, vitamin D-related behaviours and other covariates was collected prospectively from participants throughout their life. Childhood cognitive ability and educational attainment by age 42 years were strongly correlated with cognitive performance at age 50 years and with several vitamin D-related behaviours in mid-adulthood, but not with 25(OH)D concentrations at age 45 years. Participants with both low (<25 nmol/l) and high (≥75 nmol/l) 25(OH)D concentrations at age 45 years performed significantly worse on immediate word recall. The associations attenuated after adjustment for childhood cognitive ability, education, and socio-economic position; however, for the immediate word recall test, there was a non-linear association with 25(OH)D after further adjustment for obesity, menopausal status, smoking, alcohol consumption, physical activity and depressive symptoms at age 45 years (P(curvature)=0·01). The present study demonstrated that 25(OH)D concentrations were non-linearly associated with immediate word recall in mid-life. A clarification of the level of 25(OH)D concentrations that is most beneficial for predicting better cognitive performance in mid-life is required.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24135155     DOI: 10.1017/S0007114513003176

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  11 in total

1.  Vitamin D Status and Intakes and Their Association With Cognitive Trajectory in a Longitudinal Study of Urban Adults.

Authors:  May A Beydoun; Sharmin Hossain; Marie T Fanelli-Kuczmarski; Hind A Beydoun; Jose-Atilio Canas; Michele K Evans; Alan B Zonderman
Journal:  J Clin Endocrinol Metab       Date:  2018-04-01       Impact factor: 5.958

Review 2.  Role of Neural Stem Cells and Vitamin D Receptor (VDR)-Mediated Cellular Signaling in the Mitigation of Neurological Diseases.

Authors:  Chinnappa A Uthaiah; Narasimha M Beeraka; R Rajalakshmi; C M Ramya; SubbaRao V Madhunapantula
Journal:  Mol Neurobiol       Date:  2022-04-27       Impact factor: 5.590

Review 3.  Clinical Application of APOE in Alzheimer's Prevention: A Precision Medicine Approach.

Authors:  C L Berkowitz; L Mosconi; A Rahman; O Scheyer; H Hristov; R S Isaacson
Journal:  J Prev Alzheimers Dis       Date:  2018

4.  25-hydroxyvitamin D, APOE ɛ4 genotype and cognitive function: findings from the 1958 British birth cohort.

Authors:  J Maddock; A Cavadino; C Power; E Hyppönen
Journal:  Eur J Clin Nutr       Date:  2014-10-08       Impact factor: 4.016

Review 5.  Emphasizing the health benefits of vitamin D for those with neurodevelopmental disorders and intellectual disabilities.

Authors:  William B Grant; Sunil J Wimalawansa; Michael F Holick; John J Cannell; Pawel Pludowski; Joan M Lappe; Mary Pittaway; Philip May
Journal:  Nutrients       Date:  2015-02-27       Impact factor: 5.717

Review 6.  Do studies reporting 'U'-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects?

Authors:  William B Grant; Spyridon N Karras; Heike A Bischoff-Ferrari; Cedric Annweiler; Barbara J Boucher; Asta Juzeniene; Cedric F Garland; Michael F Holick
Journal:  Dermatoendocrinol       Date:  2016-05-16

Review 7.  Vitamin D, Cognition and Alzheimer's Disease: The Therapeutic Benefit is in the D-Tails.

Authors:  Véréna Landel; Cédric Annweiler; Pascal Millet; Maria Morello; François Féron
Journal:  J Alzheimers Dis       Date:  2016-05-11       Impact factor: 4.472

8.  Vitamin D and cognitive function: A Mendelian randomisation study.

Authors:  Jane Maddock; Ang Zhou; Alana Cavadino; Elżbieta Kuźma; Yanchun Bao; Melissa C Smart; Kai-Uwe Saum; Ben Schöttker; Jorgen Engmann; Marie Kjærgaard; Ville Karhunen; Yiqiang Zhan; Terho Lehtimäki; Suvi P Rovio; Liisa Byberg; Jari Lahti; Pedro Marques-Vidal; Abhijit Sen; Laura Perna; Henrik Schirmer; Archana Singh-Manoux; Juha Auvinen; Nina Hutri-Kähönen; Mika Kähönen; Lena Kilander; Katri Räikkönen; Håkan Melhus; Erik Ingelsson; Idris Guessous; Katja E Petrovic; Helena Schmidt; Reinhold Schmidt; Peter Vollenweider; Lars Lind; Johan G Eriksson; Karl Michaëlsson; Olli T Raitakari; Sara Hägg; Nancy L Pedersen; Karl-Heinz Herzig; Marjo-Riitta Järvelin; Juha Veijola; Mika Kivimaki; Rolf Jorde; Hermann Brenner; Meena Kumari; Chris Power; David J Llewellyn; Elina Hyppönen
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

9.  Obesity and depressive symptoms in mid-life: a population-based cohort study.

Authors:  Anwar Mulugeta; Ang Zhou; Christine Power; Elina Hyppönen
Journal:  BMC Psychiatry       Date:  2018-09-17       Impact factor: 3.630

10.  Prevalence of vitamin D insufficiency among children in southern china: A cross-sectional survey.

Authors:  Yong Guo; Hai-Jin Ke; Ying Liu; Min Fu; Jing Ning; Li Yu; Yu Xiao; Di Che; Xiao-Yan Chen; Yu-Hong Deng; Jie-Ling Wu
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.